metricas
covid
Neurología (English Edition) Progression of a series of patients with relapsing-remitting multiple sclerosis ...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the “no evidence of disease activity” parameter
Evolución de una serie de pacientes con esclerosis múltiple remitente-recurrente tratados con natalizumab durante 7 años mediante el parámetro no evidencia enfermedad activa
A. Pato Patoa,
Corresponding author
apatopato@gmail.com

Corresponding author.
, E. Costa Arpínb, A. Rodríguez Regalc, I. Rodríguez Constenlaa, I. Cimas Hernandoa, I. Muñoz Pousad, L. Naya Ríosd, J.R. Lorenzo Gonzáleza, M.C. Amigo Jorrínc, J.M. Prieto Gonzálezb
a Servicio de Neurología, Hospital Povisa, Vigo, Spain
b Servicio de Neurología, Hospital Clínico Universitario Santiago de Compostela, Santiago de Compostela, Spain
c Servicio de Neurología, Complejo Hospitalario de Pontevedra, Pontevedra, Spain
d Facultad de Medicina, Santiago de Compostela, Santiago de Compostela, Spain
Read
3734
Times
was read the article
757
Total PDF
2977
Total HTML
Share statistics
Article information
ISSN: 21735808
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 43 4 47
2025 11 143 31 174
2025 10 86 15 101
2025 9 77 21 98
2025 8 95 10 105
2025 7 135 15 150
2025 6 81 10 91
2025 5 68 8 76
2025 4 46 1 47
2025 3 76 8 84
2025 2 87 4 91
2025 1 81 3 84
2024 12 59 2 61
2024 11 46 8 54
2024 10 36 4 40
2024 9 57 9 66
2024 8 39 9 48
2024 7 23 6 29
2024 6 31 4 35
2024 5 23 7 30
2024 4 44 2 46
2024 3 47 14 61
2024 2 27 18 45
2024 1 34 25 59
2023 12 58 17 75
2023 11 47 10 57
2023 10 45 15 60
2023 9 22 9 31
2023 8 36 14 50
2023 7 47 7 54
2023 6 48 5 53
2023 5 94 10 104
2023 4 52 3 55
2023 3 43 6 49
2023 2 42 9 51
2023 1 43 12 55
2022 12 29 12 41
2022 11 37 24 61
2022 10 58 20 78
2022 9 26 16 42
2022 8 36 26 62
2022 7 31 24 55
2022 6 31 8 39
2022 5 59 8 67
2022 4 35 6 41
2022 3 26 11 37
2022 2 32 4 36
2022 1 53 10 63
2021 12 42 12 54
2021 11 31 7 38
2021 10 44 12 56
2021 9 17 9 26
2021 8 41 7 48
2021 7 25 22 47
2021 6 16 13 29
2021 5 17 6 23
2021 4 42 31 73
2021 3 26 4 30
2021 2 8 10 18
2021 1 15 10 25
2020 12 13 7 20
2020 11 8 5 13
2020 10 8 13 21
2020 9 17 6 23
2020 8 25 8 33
2020 7 19 8 27
2020 6 12 12 24
2020 5 15 13 28
2020 4 9 2 11
2020 3 5 7 12
2020 2 8 9 17
Show all

Follow this link to access the full text of the article